FireEye: China-linked hacking groups are increasingly targeting healthcare systems to obtain medical research data and intellectual property for medical devices
Matt Burgess / WIRED UK :
Context & Ripple Effects
FireEye's warning lands on a well-documented track record: the firm flagged suspected Chinese group TEMP.Periscope stepping up attacks on US engineering and defense companies tied to the South China Seas in its March 2018 reporting, and Bloomberg reported signs of China-sponsored hackers behind the Anthem health-insurer breach back in 2015. Symantec separately tracked the Orangeworm group hitting X-ray and MRI machines across US healthcare that same spring.
What changes here is the objective: rather than patient records or defense contracts, FireEye says the prize is medical research data and the intellectual property behind medical devices — moving Chinese-linked espionage from insurance data and defense engineering into biomedical R&D.
First-order effects
- Hospitals, research labs, and medical-device makers become direct espionage targets, with their research pipelines and device designs treated as strategic assets rather than regulated patient data.
- FireEye's healthcare-sector clients face a new threat model: the same intrusion toolkits it previously attributed to defense-industry campaigns like TEMP.Periscope's are now aimed at biomedical work.
Second-order effects
- Healthcare providers and device manufacturers are pushed toward hardening connected clinical equipment — a market Symantec's Orangeworm findings already showed is exposed through imaging hardware — boosting demand for threat intelligence vendors like FireEye.
- Insurers and regulators who treated the Anthem breach as a data-privacy event must now weigh state-sponsored theft of device IP, raising the stakes of healthcare cybersecurity beyond compliance frameworks built around patient records.
Third-order effects
- If the pattern holds, healthcare joins defense and insurance as a standing target set for China-linked espionage, collapsing the line between health-sector IT security and national-security threat assessment.
- Medical-device IP becoming a geopolitical target pressures manufacturers to treat trade secrets as export-controlled assets, foreshadowing tighter scrutiny of technology transfer in the biomedical industry.
The trend: China-linked cyber espionage is expanding sector by sector — from health-insurance records to defense engineering and now biomedical research — with each new vertical widening the definition of what counts as strategic IP.